Daphne Quimi
CIK 1543031 · Chief Financial Officer · last filed 2026-06-12
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$64.0K
Companies
3
Total Filings
62
Lifetime Open-Market Net
-$1.58M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Recent Filings · Page 3 of 7
62 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-06-10 | AMLX | Grant (A) | — | $0 | EDGAR |
| 2022-01-19 | AMICUS THERAPEUTICS, INC. (FOLD) Delisted | Mixed | +17,997 | -$198.4K | EDGAR |
| 2022-01-10 | AMLX | Grant (A) | — | $0 | EDGAR |
| 2022-01-04 | AMICUS THERAPEUTICS, INC. (FOLD) Delisted | Mixed | +41,277 | -$372.6K | EDGAR |
| 2021-04-08 | AMICUS THERAPEUTICS, INC. (FOLD) Delisted | Grant (A) | +19,295 | $0 | EDGAR |
| 2021-03-09 | AMICUS THERAPEUTICS, INC. (FOLD) Delisted | Mixed | +11,964 | $8 | EDGAR |
| 2021-01-20 | AMICUS THERAPEUTICS, INC. (FOLD) Delisted | Mixed | +4,732 | -$104.2K | EDGAR |
| 2021-01-05 | AMICUS THERAPEUTICS, INC. (FOLD) Delisted | Mixed | +10,294 | -$527.3K | EDGAR |
| 2020-12-23 | AMICUS THERAPEUTICS, INC. (FOLD) Delisted | Mixed | — | -$105.8K | EDGAR |
| 2020-12-17 | AMICUS THERAPEUTICS, INC. (FOLD) Delisted | Mixed | +26,165 | $60 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.